rxstat › Shortages › Cefazolin
Cefazolin shortage status
Widespread shortage Tier 3: critical
Source: Health Canada shortage reports · Updated Jul 9, 2026
Cefazolin is in a widespread shortage in Canada. 1 of 13 reported products are affected, and Health Canada has designated this a Tier 3 (most serious) shortage. Manufacturers have not committed to a recovery date.
In shortage since
Jun 2, 2025
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageCEFAZOLIN INJECTION, USP
20MG · SOLUTION · BAXTER CORPORATION
DIN 02496313 · since Jun 2, 2025, no end estimate · Shortage of an active ingredient.
Active shortageCEFAZOLIN INJECTION, USP
20MG · SOLUTION · BAXTER CORPORATION
DIN 02496313 · since Jun 14, 2025, no end estimate · Shortage of an active ingredient.
ResolvedCEFAZOLIN FOR INJECTION USP
1G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308959 · ended May 4, 2026 · Requirements related to complying with good manufacturing practices.
ResolvedCEFAZOLIN FOR INJECTION USP
10G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308967 · ended Apr 13, 2026 · Demand increase for the drug.
ResolvedCEFAZOLIN FOR INJECTION USP
1G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308959 · ended Feb 23, 2026 · Delay in shipping of the drug.
ResolvedCEFAZOLIN FOR INJECTION USP
10G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308967 · ended Nov 28, 2025 · Disruption of the manufacture of the drug.
ResolvedCEFAZOLIN FOR INJECTION, USP
100G · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02401029 · ended Nov 11, 2025 · Delay in shipping of the drug.
ResolvedCEFAZOLIN FOR INJECTION USP
500MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02308932 · ended Jan 8, 2024 · Demand increase for the drug.
DiscontinuedCEFAZOLIN FOR INJECTION
10G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02108135
ResolvedCEFAZOLIN FOR INJECTION
1G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02108127 · ended Aug 3, 2023 · Disruption of the manufacture of the drug.
ResolvedCEFAZOLIN FOR INJECTION
10G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02437120 · ended Jun 30, 2023 · Delay in shipping of the drug.
ResolvedCEFAZOLIN FOR INJECTION
1G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02108127 · ended Jul 5, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 48 reports. All reports are on file with Health Canada.
What's happening
Cefazolin is currently affected by an active shortage report filed with Health Canada by BAXTER CORPORATION.
The reported cause is: shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
Health Canada has flagged this as a Tier 3 shortage, its most serious category, meaning the shortage has the greatest potential impact on the health system and alternatives are limited.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Cefazolin is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DB).
Recent changes
Common questions
When will Cefazolin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Cefazolin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All other beta-lactam antibacterials shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.